AJ

Advait Jajodia

Active Director Director DIN 10206306
DIN 10206306 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Advait Jajodia

Data last updated:

Advait Jajodia is a Director at Alcon Biosciences Private Limited (since 2023). The company operates in Pharma. Alcon Biosciences Private Limited reported revenue of ₹125 Cr (FY 2025).

DIN 10206306
Primary Designation Director
Industry Pharma
First Appointment 24 Jun 2023
Oldest Company Age 44 yrs
Largest company Alcon Biosciences Private Limited · ₹125 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alcon Biosciences Private Limited U24230MH1982PTC026953
Director24 Jun 20231982₹125 Cr (FY 2025)Active

Board colleagues of Advait Jajodia

Directorship timeline

Open interactive timeline →
Alcon Biosciences Private Limited
Premium access

Shareholding and investment profile for Advait Jajodia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Advait Jajodia

Advait Jajodia currently holds 1 directorship: Alcon Biosciences Private Limited (Director, since 24 Jun 2023, revenue ₹125 Cr (FY 2025)).

Advait Jajodia was first appointed on 24 Jun 2023 as Director at Alcon Biosciences Private Limited.

The current boards of Advait Jajodia's companies include Ashutosh Radheshyam Tripathi (Alcon Biosciences Private Limited), Vishal Narayanprasad Jajodia (Alcon Biosciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available